Intellectual Property

Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.



Sign up for a 7-day FREE trial today!



Latest News in Intellectual Property

  • July 09, 2026

    'Bye Bye Bye' Choreographer Drops Sony Copyright Claims

    The artist behind NSYNC's iconic "Bye Bye Bye" choreography has dropped his claims against Sony Music Holdings Inc. over allegations that the company licensed the dance for use in Marvel Studios' 2024 movie "Deadpool & Wolverine" and Epic Games' video game Fortnite without his permission or giving him credit.

  • July 09, 2026

    $500M Medical Glove Contract Breach Suit Sent To Arbitration

    A Malaysia-based distributor must arbitrate its $500 million suit against a medical gloves supplier in a case stemming from a COVID-19 era agreement aimed at supplying nitrile gloves to Walmart for resale, finding an exception to arbitration for intellectual property disputes did not apply to the claims.

  • July 08, 2026

    Samsung Accuses Netlist Of Patent 'Double-Dip' In Latest Suit

    Samsung has kicked off yet another lawsuit in its long-running intellectual property dispute with Netlist, this time claiming that Netlist is trying to "double dip" with a demand that Samsung take a second license to Netlist's patents covering semiconductor technology, according to a complaint filed in Delaware federal court Wednesday.

  • July 08, 2026

    Hachette Gets AI Book Cover IP Claims Tossed, For Now

    A New York federal judge on Wednesday tossed a freelance artist's claims that Hachette Book Group used artificial intelligence to create derivative book covers of copyrighted artwork for books authored by romance and thriller novelist Sandra Brown, saying he has not shown substantial similarity between his art and the accused covers.

  • July 08, 2026

    Jazz Patent Suit Over Xyrem Survives Dismissal In NJ

    A New Jersey federal judge has refused to let generic-drug company Tris Pharma Inc. escape a suit claiming its attempt to sell a competing version of Jazz Pharmaceuticals' narcolepsy drug Xyrem infringes a series of patents.

See more Intellectual Property news

Intellectual Property

Areas of Coverage

  • LITIGATION
  • Infringement suits over patents, copyrights, and trademarks
  • Patent Trial and Appeal Board disputes
  • Abbreviated New Drug Application (ANDA) litigation
  • Section 301 cases
  • Trade secrets disputes
  • Licensing and royalty fights
  • Right-of-publicity suits
  • Antitrust disputes involving IP issues
  • AGENCIES
  • U.S. Patent and Trademark Office
  • U.S. Copyright Office
  • U.S. International Trade Commission
  • World Intellectual Property Organization
  • POLICY & REGULATION
  • Patent reform legislation and related bills in Congress
  • Efforts to streamline international intellectual property law
  • ENFORCEMENT
  • Piracy and counterfeiting actions
  • International trade disputes involving IP issues
  • PROFILES
  • Personnel moves
  • Profiles of IP practices

Readership

  • Intellectual property lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the life sciences, technology, and other IP-focused industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals